Shattuck Labs
STTK
74 hedge funds and large institutions have $132M invested in Shattuck Labs in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 17 closing their positions.
81% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 16
35% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 17
7% more funds holding
Funds holding: 69 → 74 (+5)
5.6% more ownership
Funds ownership: 66.27% → 71.88% (+5.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
53% less capital invested
Capital invested by funds: $281M → $132M (-$149M)
78% less call options, than puts
Call options by funds: $24K | Put options by funds: $109K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15.8M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$7.68M |
| 3 |
State Street
Boston,
Massachusetts
|
+$4.51M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.93M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TPC
Takeda Pharmaceutical Company
Tokyo,
Japan
|
-$8.01M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$5.91M |
| 3 |
Millennium Management
New York
|
-$4.19M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.75M |
| 5 |
Jane Street
New York
|
-$2.63M |
STTK Hedge Fund Activity: Q2 2024 in Review
74 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Shattuck Labs (STTK) for Q2 2024, worth a combined $132M — down 53% from $281M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new STTK positions and 17 closed out — a net gain of 6 holders — while 29 added to existing stakes and 16 trimmed.
The largest buyer was BlackRock, adding an estimated $15.8M. The largest seller was Takeda Pharmaceutical Company, cutting an estimated $8.01M.
- 74 institutional investors held Shattuck Labs (STTK) as of Q2 2024, up from 69 in Q1 2024.
- Funds reported $132M of Shattuck Labs stock for Q2 2024, down 53% quarter-over-quarter.
- 23 funds opened new Shattuck Labs positions in Q2 2024 and 17 closed out, a net change of +6 holders.
- The largest Shattuck Labs buyer in Q2 2024 was BlackRock, an estimated $15.8M added.
- The largest Shattuck Labs seller in Q2 2024 was Takeda Pharmaceutical Company, an estimated $8.01M sold.
Based on aggregated 13F filings for Q2 2024.